Effect of high glucose on superoxide in human mesangial cells: Role of angiotensin II

Nephron - Experimental Nephrology

Volumn 100, Issue 1, 2005, Pages 46-53

  Leehey, David J ^a,b   Isreb, Majd A ^a,b   Marcic, Sonja ^a,b   Singh, Ashok K ^c   Singh, Rekha ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c Hektoen Institute for Medical Research   (United States)

Author keywords

Angiotensin II; High glucose; NADH NADPH oxidase; Superoxide; Superoxide dismutase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; APOCYNIN; DEOXYGLUCOSE; DIPHENYLENEIODONIUM CHLORIDE; ENZYME INHIBITOR; GLUCOSE; IRBESARTAN; LOSARTAN; LUCIGENIN; MANNITOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL LYSATE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; MESANGIUM CELL; OSMOSIS; OXYGEN CONCENTRATION; PRIORITY JOURNAL;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; CELL CULTURE TECHNIQUES; DIABETIC NEPHROPATHIES; GLUCOSE; HUMANS; KIDNEY GLOMERULUS; LOSARTAN; OXIDANTS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TETRAZOLES;

EID: 18744411278     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084348     Document Type: Article

References (38)

1. Lee HB, Yu R-B, Yang Y, Jiang Z, Ha H: Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003;14(suppl 3):S19-S25.
2. Koya D, Lee IK, Ishihi H, Hanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol 1997;8:426-435.
3. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderama E, Fuchs A: Taurine ameliorated chronic streptozotocin-induced diabetic nephropathy in rats. Am J Physiol 1995;269:F429-F438.
4. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK: Effect of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes. J Am Soc Nephrol 1997;8:1405-1411.
5. Trachtman H: Vitamin E prevents glucose induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc Res 1994;47:232-239.
6. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999;22:1245-1251.
7. Wolff SP, Dean RT: Glucose autoxidation and protein oxidation: The role of autoxidative glycosylation in diabetes mellitus and ageing. Biochem J 1987;245:243-250.
8. Yan SD, Schmidt AM, Anderson GM: Enhanced cellular oxidant stress by the interaction of advanced glycosylation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889-9897.
9. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998;54:775-784.
10. Singh R, Alavi N, Singh AK, Leehey DJ: Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 1999;48:2066-2073.
11. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int 2000;77:S93-S98.
12. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ: High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta 1. Exp Nephrol 2001;9:249-257.
13. Craven PA, Phillips SL, Melhem MF, Liachenko J, DeRubertis FR: Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose. Metabolism 2001;50:1043-1048.
14. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Yasufumi K, Yorek MA, Beebe D, Oates PJ, Hammes H, Glardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
15. Singh R, Singh AK, Alavi N, Leehey DJ: Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003;14:873-880.
16. Reddi AS, Bollineni JS: Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem Biophys Res Commun 1997;235:598-601.
17. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N: Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J Biol Chem 1987;262:16969-16972.
18. Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER: Glucose-induced oxidative stress in mesangjal cells. Kidney Int 2002;61:599-608.
19. Li J-M, Shah AM: ROS generation by non-phagocytic NADPH oxidase: Potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003;14:8221-8226.
20. Gorin Y, Ricono JM, Kim H-N, Bhandari B, Choudhury GG, Abboud HE: Nox4 mediates angiotensin Il-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol 2003;285:F219-229.
21. Li J, Shah AM: Mechanism of endothelial cell NADPH oxidase activation by angiotensin II: Role of the p47phox subunit. J Biol Chem 2003;278:12094-12100.
22. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG: Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002;40:511-515.
23. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M: Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003;52:2603-2614.
24. Inoguchi T, Li P, Umeda F, et al: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000;49:1939-1945.
25. Etoh T, Inoguchi T, Kakimoto M, et al: Increased expression of NAD(P)H oxidase subunits, nox4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia 2003;46:1428-1437.
26. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS: Angiotensin II induces gene transcription through cell-type dependent effects on the nuclear factor-κB (NF-κB) transcription factor. Mol Cell Biochem 2000;212:155-169.
27. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001;44:1957-1972.
28. Kranzhofer R, Browatzki M, Schmidt J, Kubler W: Angiotensin II activates the proinflammatory transcription factor-κB in human monocytes. Biochem Biophys Res Commun 1999;257:826-828.
29. 1 receptor-knockout mice. J Am Soc Nephrol 2002;13:1162-1171.
30. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 2001;10:2247-2258.
31. Palmer HJ, Paulson KE: Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 1997;55:353-361.
32. Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997;22:269-285.
33. Li J, Brasier AR: Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 1996;10:252-264.
34. Zhang SL, To C, Chen X, Filep JG, Tang SS, Ingelfinger JR, Carriere S, Chan JS: Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells. Exp Nephrol 2001;9:109-117.
35. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002;39:316-322.
36. Kuroki T, Isshiki K, King GL: Oxidative stress: The lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003;14:S216-S220.
37. Koo JR, Vaziri ND: Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003;63:195-201.
38. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 2002;61:186-194.